Liver stiffness measurement

Biomarker7 papers4 findings

Human trial1
Humans6

Interventions

2

Bariatric surgery

downin humans1Very low certainty

1 study

Bariatric surgery decreases liver stiffness measurement in humans (-4.9 ± 1.1 kPa).
Humansin obesity with MASLD72 weeksn = 32
Effects of Semaglutide versus Bariatric Surgery on Noninvasive Markers of Hepatic Steatosis and Fibrosis in Obesity with MASLD · The Journal of clinical endocrinology and metabolism · 27 Aug 2026

Bariatric surgery →

Semaglutide

downin humans1Very low certainty

1 study

Semaglutide decreases liver stiffness measurement in humans (-2.8 ± 0.8 kPa).
Humansin obesity with MASLD72 weeksn = 30
Effects of Semaglutide versus Bariatric Surgery on Noninvasive Markers of Hepatic Steatosis and Fibrosis in Obesity with MASLD · The Journal of clinical endocrinology and metabolism · 27 Aug 2026

Semaglutide →

Associations

2

Depersonalisation

upin humans1

1 study

Depersonalisation is associated with liver stiffness measurement in humans (β = 0.106 kPa per point; 95% CI 0.025 to 0.187; P = 0.011).
Humansadjusted for age, sex, body mass index, and glycated haemoglobinn = 106
Burnout, resilience, and cardiometabolic phenotype in an academic medical faculty: an integrated cross-sectional assessment from the United Arab Emirates · Frontiers in endocrinology · 17 Aug 2026

Emotional exhaustion

upin humans1

1 study

Emotional exhaustion is associated with liver stiffness measurement in humans (β = 0.061 kPa per point; 95% CI 0.022 to 0.100; P = 0.002).
Humansadjusted for age, sex, body mass index, and glycated haemoglobinn = 106
Burnout, resilience, and cardiometabolic phenotype in an academic medical faculty: an integrated cross-sectional assessment from the United Arab Emirates · Frontiers in endocrinology · 17 Aug 2026

Latest

12

Frontiers in Digital HealthHumans1 h

Development of a machine learning model to identify individuals with VCTE-derived at-risk MASH in a Spanish Mediterranean region

Frontiers in MedicineReview16 Sep

A fibrosis-informed refinement of the intermediate-risk stratum for statin allocation: a liver-derived hypothesis anchored to the 2026 PREVENT-based guideline framework

Liver InternationalHumans15 Sep

ALPS-HCC Score: A Dynamic Liver Stiffness Measurement-Based Machine Learning Model to Predict Risk of Hepatocellular Carcinoma

Hepatocellular carcinoma

Journal of Frailty, Sarcopenia and FallsHumans3 Sep

Sarcopenia in Indian Males Having Clinically Significant Liver Fibrosis in Type 2 Diabetes: A Tertiary-Centre Cross-Sectional Study to Estimate the Prevalence and Associated Factors

Frontiers in EndocrinologyHumans1 Sep

Burnout, resilience, and cardiometabolic phenotype in an academic medical faculty: an integrated cross-sectional assessment from the United Arab Emirates

Journal of Gastroenterology and HepatologyHumans28 Aug

Comparable Predictive Performance of Non-VCTE-Based Machine Learning Model for HBV-Infected Hepatocellular Carcinoma Risk

Hepatocellular carcinoma

The Journal of Clinical Endocrinology and MetabolismHumans27 Aug

Effects of Semaglutide versus Bariatric Surgery on Noninvasive Markers of Hepatic Steatosis and Fibrosis in Obesity with MASLD

Diabetes Research and Clinical PracticeHuman trial25 Aug

Efficacy of dapagliflozin on hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: a pre-specified single-arm analysis from a randomized controlled trial

ADA Scientific Sessions 2026 AbstractHumans6 Jun

Waist-to-Height Ratio Outperforms BMI in Identifying Hepatic Steatosis and Fibrosis in U.S. Adults

ADA Scientific Sessions 2026 AbstractHumans6 Jun

Divergent Risk Profiles of Diabetes Progression in Lean and Obese Prediabetes